Long-term safety of gaboxadol in the treatment of elderly patients with primary insomnia: A 12month, double-blind, placebo-controlled clinical trial

被引：0
|
作者：
Bodkin, J.
Anderson, D.
Zheng, Y.
Golm, G.
Gottwald, R.
Kametz, K.
机构：
[1] McLean Hosp, Belmont, MA 02178 USA
[2] Anderson Clin Res, Redlands, CA USA
[3] Merck Res Labs, N Wales, PA USA
来源：
SLEEP | 2007年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
702
引用
收藏
页码：A238 / A239
页数：2
相关论文
共 50 条
  • [1] Efficacy and tolerability of gaboxadol in adults with primary insomnia: A 3-month, randomized, double-blind, placebo-controlled trial
    Anderson, D.
    Roth, T.
    Zheng, Y.
    Vandormael, K.
    Smith, A.
    Li, M.
    Digravio, D.
    [J]. SLEEP, 2007, 30 : A234 - A234
  • [2] Efficacy and tolerability of gaboxadol in elderly patients with chronic primary insomnia: A 6-month double-blind, placebo-controlled outpatient study
    Hedner, J.
    Loft, H.
    Hajak, G.
    Lundahl, J.
    Hedegaard, K.
    Knoth, Sorensen H.
    Torstenson, R.
    [J]. SLEEP, 2007, 30 : A252 - A253
  • [3] The effect of magnesium supplementation on primary insomnia in elderly: A double-blind placebo-controlled clinical trial
    Abbasi, Behnood
    Kimiagar, Masud
    Sadeghniiat, Khosro
    Shirazi, Minoo M.
    Hedayati, Mehdi
    Rashidkhani, Bahram
    [J]. JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2012, 17 (12): : 1161 - 1169
  • [4] Long-term safety of the tafenoquine antimalarial chemoprophylaxis regimen: A 12-month, randomized, double-blind, placebo-controlled trial
    Novitt-Moreno, Anne
    Martidis, Adam
    Gonzalez, Victor
    Ransom, Janet
    Scott, Charles B.
    Dow, Geoffrey
    Reid, Mark
    Smith, Bryan
    Zottig, Victor E.
    Read, Lisa Thomas
    Baldwin, Lindsey S. Garver
    Chen, Fred K.
    [J]. TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2022, 45
  • [5] Long-term nightly treatment with indiplon in adults with primary insomnia: Results of a double-blind, placebo-controlled, 3-month study
    Scharf, Martin B.
    Black, Jed
    Hull, Steven
    Landin, Rick
    Farber, Robert
    [J]. SLEEP, 2007, 30 (06) : 743 - 752
  • [6] Double-blind, placebo-controlled outpatient clinical trial of ramelteon for the treatment of chronic insomnia in an elderly population
    Seiden, D
    Zee, P
    Weigand, S
    Sainati, S
    Bayuk, J
    Zhang, J
    Roth, T
    [J]. SLEEP, 2005, 28 : A228 - A228
  • [7] The effects of tiagabine in elderly patients with primary insomnia: A double-blind, placebo-controlled study
    Wright, KP
    Roth, T
    [J]. SLEEP, 2005, 28 : A250 - A250
  • [8] Efficacy and tolerability of gaboxadol in elderly patients with chronic primary insomnia: A 4-week, double-blind, placebo-controlled outpatient study
    Hedner, J.
    Loft, H.
    Hajak, G.
    Lundahl, J.
    Hedegaard, K.
    Knoth, Sorensen H.
    Torstenson, R.
    [J]. SLEEP, 2007, 30 : A249 - A249
  • [9] Zolpidem in the treatment of short-term insomnia: A randomized, double-blind, placebo-controlled clinical trial
    Dockhorn, RJ
    Dockhorn, DW
    [J]. CLINICAL NEUROPHARMACOLOGY, 1996, 19 (04) : 333 - 340
  • [10] Long-term cariprazine treatment for the prevention of relapse in patients with schizophrenia: a double-blind, placebo-controlled trial
    Durgam, S.
    Earley, W.
    Li, R.
    Li, D.
    Lu, K.
    Laszlovszky, I.
    Fleischhacker, W. W.
    Lieberman, J. A.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S512 - S513
12345